1,748
Views
84
CrossRef citations to date
0
Altmetric
Perspectives

Reviewing once more the c-myc and Ras collaboration

Converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology

, &
Pages 57-67 | Published online: 01 Jan 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Niranjan Venkateswaran & Maralice Conacci-Sorrell. (2020) MYC leads the way. Small GTPases 11:2, pages 86-94.
Read now
Rajendra Karki, R. K. Subbarao Malireddi, Qifan Zhu & Thirumala-Devi Kanneganti. (2017) NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer. Cell Cycle 16:13, pages 1243-1251.
Read now
Dimo Dietrich, Sebastian Meller, Barbara Uhl, Bernhard Ralla, Carsten Stephan, Klaus Jung, Jörg Ellinger & Glen Kristiansen. (2014) Nucleic acid-based tissue biomarkers of urologic malignancies. Critical Reviews in Clinical Laboratory Sciences 51:4, pages 173-199.
Read now
Yuan Sun, Xiaomin Lou, Min Yang, Chengfu Yuan, Ling Ma, Bing-Kun Xie, Jian-min Wu, Wei Yang, Xiang Jun Shen, Ningzhi Xu & D. Joshua Liao. (2013) Cyclin-dependent kinase 4 may be expressed as multiple proteins and have functions that are independent of binding to CCND and RB and occur at the S and G2/M phases of the cell cycle. Cell Cycle 12:22, pages 3512-3525.
Read now
Rebecca Lamb, Sophie Lehn, Lynsey Rogerson, Robert B Clarke & Göran Landberg. (2013) Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity. Cell Cycle 12:15, pages 2384-2394.
Read now
Olga V. Leontieva, Felicia Lenzo, Zoya N. Demidenko & Mikhail V. Blagosklonny. (2012) Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells. Cell Cycle 11:24, pages 4642-4649.
Read now

Articles from other publishers (77)

Zinab O. Doha & Rosalie C. Sears. (2023) Unraveling MYC’s Role in Orchestrating Tumor Intrinsic and Tumor Microenvironment Interactions Driving Tumorigenesis and Drug Resistance. Pathophysiology 30:3, pages 400-419.
Crossref
Jiaao Sun, Liyan Yu, Xueling Qu & Tao Huang. (2023) The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy. Frontiers in Pharmacology 14.
Crossref
Junhong Ye, Jifu Li & Ping Zhao. (2023) The Silkworm Carboxypeptidase Inhibitor Prevents Gastric Cancer Cells’ Proliferation through the EGF/EGFR Signaling Pathway. International Journal of Molecular Sciences 24:2, pages 1078.
Crossref
René Winkler, Eva-Maria Piskor & Christian Kosan. (2022) Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma. Cells 12:1, pages 37.
Crossref
Xiaoning Han, Yongjie Wei, Ru Ba, Lijuan Sun & Chunjie Zhao. (2022) PDK1 regulates the lengthening of G1 phase to balance RGC proliferation and differentiation during cortical neurogenesis. Cerebral Cortex 32:16, pages 3488-3500.
Crossref
Andrea Arena, Maria Anele Romeo, Rossella Benedetti, Maria Saveria Gilardini Montani & Mara Cirone. (2022) The impairment of DDR reduces XBP1s, further increasing DNA damage, and triggers autophagy via PERK/eIF2alpha in MM and IRE1alpha/JNK1/2 in PEL cells. Biochemical and Biophysical Research Communications 613, pages 19-25.
Crossref
Madhu Sharma, Avijit Kumar Bakshi, Naresh Mittapelly, Shalini Gautam, Disha Marwaha, Nikhil Rai, Neha Singh, Pratiksha Tiwari, Neha Agarwal, Ankit Kumar & Prabhat Ranjan Mishra. (2022) Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer. Journal of Controlled Release 346, pages 43-70.
Crossref
Edward J. Perkins, E. Alice Woolard & Natàlia Garcia-Reyero. (2022) Integration of Adverse Outcome Pathways, Causal Networks and ‘Omics to Support Chemical Hazard Assessment. Frontiers in Toxicology 4.
Crossref
Jyh-Der Leu, Chung-Yih Wang, Chia-Chien Lo, Min-Ying Lin, Chun-Yuan Chang, Wen-Chin Hung, Shi-Ting Lin, Bo-Shen Wang & Yi-Jang Lee. (2021) Involvement of c-Myc in low dose radiation-induced senescence enhanced migration and invasion of unirradiated cancer cells. Aging 13:18, pages 22208-22231.
Crossref
Zhiwen Li, Xu Zhou, Huaqiang Zhu, Xie Song, Hengjun Gao, Zheyu Niu & Jun Lu. (2020) Purpurin binding interacts with LHPP protein that inhibits PI3K/AKT phosphorylation and induces apoptosis in colon cancer cells HCT‐116. Journal of Biochemical and Molecular Toxicology 35:3.
Crossref
Jordan L. Kohlmeyer, David J. Gordon, Munir R. Tanas, Rebecca D. Dodd, Varun Monga, Benjamin W. Darbro & Dawn E. Quelle. (2021) Combination therapies for MPNSTs targeting RABL6A-RB1 signaling. Oncotarget 12:1, pages 10-14.
Crossref
Saffiya Habib, Mario Ariatti & Moganavelli Singh. (2020) Anti-c-myc RNAi-Based Onconanotherapeutics. Biomedicines 8:12, pages 612.
Crossref
Olga V. Anatskaya, Alexander E. Vinogradov, Ninel M. Vainshelbaum, Alessandro Giuliani & Jekaterina Erenpreisa. (2020) Phylostratic Shift of Whole-Genome Duplications in Normal Mammalian Tissues towards Unicellularity Is Driven by Developmental Bivalent Genes and Reveals a Link to Cancer. International Journal of Molecular Sciences 21:22, pages 8759.
Crossref
Jordan L Kohlmeyer, David J Gordon, Munir R Tanas, Varun Monga, Rebecca D Dodd & Dawn E Quelle. (2020) CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets. International Journal of Molecular Sciences 21:8, pages 3018.
Crossref
Yan Gu, Xiaozeng Lin, Anil Kapoor, Mathilda Jing Chow, Yanzhi Jiang, Kuncheng Zhao & Damu Tang. (2020) The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert. Genes 11:3, pages 312.
Crossref
John W. PhillipsYang PanBrandon L. TsaiZhijie XieLevon DemirdjianWen XiaoHarry T. Yang, Yida ZhangChia Ho LinDonghui ChengQiang HuSong LiuDouglas L. Black, Owen N. WitteYi Xing. (2020) Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers. Proceedings of the National Academy of Sciences 117:10, pages 5269-5279.
Crossref
Udom Lao-On, Pinnara Rojvirat, Pakkanan Chansongkrow, Phatchariya Phannasil, Siraprapa Siritutsoontorn, Varodom Charoensawan & Sarawut Jitrapakdee. (2020) c-Myc directly targets an over-expression of pyruvate carboxylase in highly invasive breast cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:3, pages 165656.
Crossref
Sujatha Peela, Dariya Begum & Ganji Purnachandra Nagaraju. 2020. Novel therapeutic approaches for gastrointestinal malignancies. Novel therapeutic approaches for gastrointestinal malignancies 193 207 .
María Luisa Hernández-Bule, Enrique Medel, Clara Colastra, Raquel Roldán & Alejandro Úbeda. (2019) Response of neuroblastoma cells to RF currents as a function of the signal frequency. BMC Cancer 19:1.
Crossref
Silvia Cecilia Pacheco-Velázquez, Juan Carlos Gallardo-Pérez, Daniel Díaz, Alhelí Adán-Ladrón de Guevara, Diana Xochiquetzal Robledo-Cadena, Emma Saavedra, Luz Ruiz-Godoy, Luis Roberto Jimenez-Hernández, Jesús Vargas-Barrón, José Luis Aguilar-Ponce & Sara Rodríguez-Enríquez. (2019) Heart myxoma develops oncogenic and metastatic phenotype. Journal of Cancer Research and Clinical Oncology 145:5, pages 1283-1295.
Crossref
Yanzhi Jiang, Xiaozeng Lin, Anil Kapoor, Lizhi He, Fengxiang Wei, Yan Gu, Wenjuan Mei, Kuncheng Zhao, Huixiang Yang & Damu Tang. (2019) FAM84B promotes prostate tumorigenesis through a network alteration. Therapeutic Advances in Medical Oncology 11, pages 175883591984637.
Crossref
Mei‑Ying Zhang, Li‑Yuan Wang, Shuang Zhao, Xiao‑Chong Guo, Ying‑Qi Xu, Zhi‑Hong Zheng, Hang Lu & Hua‑Chuan Zheng. (2018) Effects of Beclin 1 overexpression on aggressive phenotypes of colon cancer cells. Oncology Letters.
Crossref
Xingde Liu, Wenxiu Yang, Zhizhong Guan, Wenfeng Yu, Bin Fan, Ningzhi Xu & D. Joshua Liao. (2018) There are only four basic modes of cell death, although there are many ad-hoc variants adapted to different situations. Cell & Bioscience 8:1.
Crossref
Tianxiang Hu, Qing Wu, Yating Chong, Haiyan Qin, Candace J. Poole, Jan van Riggelen, Mingqiang Ren & John K. Cowell. (2018) FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome. Leukemia 32:11, pages 2363-2373.
Crossref
Adriana Harbuzariu, Gabriela Oprea-Ilies & Ruben R. Gonzalez-Perez. 2018. Advances in Pancreatic Cancer. Advances in Pancreatic Cancer.
Jiangli Zheng, Xue Dai, Hailin Chen, Chunli Fang, Jian Chen & Lizhou Sun. (2018) Down-regulation of LHPP in cervical cancer influences cell proliferation, metastasis and apoptosis by modulating AKT. Biochemical and Biophysical Research Communications 503:2, pages 1108-1114.
Crossref
Mannu K. Walia, Scott Taylor, Patricia W. M. Ho, T. John Martin & Carl R. Walkley. (2018) Tolerance to sustained activation of the cAMP/Creb pathway activity in osteoblastic cells is enabled by loss of p53. Cell Death & Disease 9:9.
Crossref
Andrea Antonosante, Michele d’Angelo, Vanessa Castelli, Mariano Catanesi, Dalila Iannotta, Antonio Giordano, Rodolfo Ippoliti, Elisabetta Benedetti & Annamaria Cimini. (2018) The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells. International Journal of Molecular Sciences 19:7, pages 1907.
Crossref
Jean‐Nicolas Gallant & Christine M Lovly. (2018) Established, emerging and elusive molecular targets in the treatment of lung cancer. The Journal of Pathology 244:5, pages 565-577.
Crossref
Yin Yu, Zhixin Wang, Daju Sun, Xueying Zhou, Xin Wei, Wei Hou, Youpeng Ding, Yanan Ma & Yi Hou. (2018) miR-671 promotes prostate cancer cell proliferation by targeting tumor suppressor SOX6. European Journal of Pharmacology 823, pages 65-71.
Crossref
Christopher C. Mills, EA. Kolb & Valerie B. Sampson. (2018) Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy. Cancer Research 78:2, pages 320-325.
Crossref
Mei-Ling Chan, Chia-Chun Yu, Jui-Ling Hsu, Wohn-Jenn Leu, She-Hung Chan, Lih-Ching Hsu, Shih-Ping Liu, Polina M. Ivantcova, Özdemir Dogan, Stefan Bräse, Konstantin V. Kudryavtsev & Jih-Hwa Guh. (2017) Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways. Oncotarget 8:57, pages 96668-96683.
Crossref
Roderik M. Kortlever, Nicole M. Sodir, Catherine H. Wilson, Deborah L. Burkhart, Luca Pellegrinet, Lamorna Brown Swigart, Trevor D. Littlewood & Gerard I. Evan. (2017) Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell 171:6, pages 1301-1315.e14.
Crossref
Bela Ozsvari, Federica Sotgia & Michael P. Lisanti. (2017) A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis. Aging 9:10, pages 2098-2116.
Crossref
Ying Gu, Jiawei Zhang, Xiaoxiao Ma, Byung-wook Kim, Hailong Wang, Jinfan Li, Yi Pan, Yang Xu, Lili Ding, Lu Yang, Chao Guo, Xiwei Wu, Jun Wu, Kirk Wu, Xiaoxian Gan, Gang Li, Ling Li, Stephen J. Forman, Wing-Chung Chan, Rongzhen Xu & Wendong Huang. (2017) Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma. Cancer Cell 32:1, pages 115-128.e7.
Crossref
Wei Xia, Chung Mau Lo, Randy Y.C. Poon, Tan To Cheung, Albert C.Y. Chan, Lin Chen, Sitian Yang, George S.W. Tsao & Xiao Qi Wang. (2017) Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells. Oncotarget 8:24, pages 38811-38824.
Crossref
Upasana Sahu, Arnab Choudhury, Suhel Parvez, Subhrajit Biswas & Sudeshna Kar. (2017) Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death & Disease 8:3, pages e2667-e2667.
Crossref
Xinan Yang, Fangming Tang, Jisu Shin & John M. Cunningham. (2017) A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature). Scientific Reports 7:1.
Crossref
Min Ye, Wei Huang, Wen-wei Wu, Yang Liu, Sheng-nan Ye & Jian-hua Xu. (2017) FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition. Oncotarget 8:9, pages 15364-15376.
Crossref
Wohn-Jenn Leu, Sharada Prasanna Swain, She-Hung Chan, Jui-Ling Hsu, Shih-Ping Liu, Mei-Ling Chan, Chia-Chun Yu, Lih-Ching Hsu, Yen-Lin Chou, Wei-Ling Chang, Duen-Ren Hou & Jih-Hwa Guh. (2016) Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways. Oncotarget 7:47, pages 76995-77009.
Crossref
Alejandro Vazquez-Martin, Olga V. Anatskaya, Alessandro Giuliani, Jekaterina Erenpreisa, Sui Huang, Kristine Salmina, Inna Inashkina, Anda Huna, Nikolai N. Nikolsky & Alexander E. Vinogradov. (2016) Somatic polyploidy is associated with the upregulation of c-MYC interacting genes and EMT-like signature. Oncotarget 7:46, pages 75235-75260.
Crossref
Hitoshi Aihara, Takeya Nakagawa, Hirofumi Mizusaki, Mitsuhiro Yoneda, Masanori Kato, Masamichi Doiguchi, Yuko Imamura, Miki Higashi, Tsuyoshi Ikura, Tomonori Hayashi, Yoshiaki Kodama, Masaya Oki, Toshiyuki Nakayama, Edwin Cheung, Hiroyuki Aburatani, Ken-ichi Takayama, Haruhiko Koseki, Satoshi Inoue, Yukio Takeshima & Takashi Ito. (2016) Histone H2A T120 Phosphorylation Promotes Oncogenic Transformation via Upregulation of Cyclin D1. Molecular Cell 64:1, pages 176-188.
Crossref
S Diersch, M Wirth, C Schneeweis, S Jörs, F Geisler, J T Siveke, R Rad, R M Schmid, D Saur, A K Rustgi, M Reichert & G Schneider. (2015) KrasG12D induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells. Oncogene 35:29, pages 3880-3886.
Crossref
Tian Yang, Bin Song, Jin Zhang, Guang-Shun Yang, Han Zhang, Wei-Feng Yu, Meng-Chao Wu, Jun-Hua Lu & Feng Shen. (2016) STK33 promotes hepatocellular carcinoma through binding to c-Myc. Gut 65:1, pages 124-133.
Crossref
Bo Tang, Zhigao Hu, Yang Li, Shengguang Yuan, Zhenran Wang, Shuiping Yu & Songqing He. (2015) Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU. Molecular Medicine Reports.
Crossref
Bingya Liu, Lewis Ezeogu, Lucas Zellmer, Baofa Yu, Ningzhi Xu & Dezhong Joshua Liao. (2015) Protecting the normal in order to better kill the cancer. Cancer Medicine 4:9, pages 1394-1403.
Crossref
Hannah Winifred Child, Yulán Hernandez, João Conde, Margaret Mullin, Pedro Baptista, Jesus Maria de la Fuente & Catherine Cecilia Berry. (2015) Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects. Nanomedicine 10:16, pages 2513-2525.
Crossref
Fernanda Gonçalves de Andrade, Suely Kazue Nagahashi Marie, Miyuki Uno, Hamilton Matushita, Mario Augusto Taricco, Manoel Jacobsen Teixeira, Sergio Rosemberg & Sueli Mieko Oba-Shinjo. (2015) Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases. Neuropathology 35:4, pages 312-323.
Crossref
Guan Yang, Yansong Xue, Hanying Zhang, Min Du & Mei-Jun Zhu. (2015) Favourable effects of grape seed extract on intestinal epithelial differentiation and barrier function in IL10-deficient mice. British Journal of Nutrition 114:1, pages 15-23.
Crossref
Steven D. Horne, Sarah A. Pollick & Henry H.Q. Heng. (2015) Evolutionary mechanism unifies the hallmarks of cancer. International Journal of Cancer 136:9, pages 2012-2021.
Crossref
Jason M. God, Christine Cameron, Janette Figueroa, Shereen Amria, Azim Hossain, Bettina Kempkes, Georg W. Bornkamm, Robert K. Stuart, Janice S. Blum & Azizul Haque. (2015) Elevation of c-MYC Disrupts HLA Class II–Mediated Immune Recognition of Human B Cell Tumors. The Journal of Immunology 194:4, pages 1434-1445.
Crossref
HUI LI, KAIJUN LUO & JUAN HOU. (2015) Inhibitory effect of Puerariae radix flavones on platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells via PI3K and ERK pathways. Experimental and Therapeutic Medicine 9:1, pages 257-261.
Crossref
Xiao Wang, Jian Wu, Yiwei Lin, Yi Zhu, Xianglai Xu, Xin Xu, Zhen Liang, Shiqi Li, Zhenghui Hu, Xiangyi Zheng & Liping Xie. (2014) MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6. Journal of Experimental & Clinical Cancer Research 33:1.
Crossref
C Zhang, S Zhang, Z Zhang, J He, Y Xu & S Liu. (2013) ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc. Oncogene 33:49, pages 5582-5591.
Crossref
Akriti Kharbanda, Hasan Rajabi, Caining Jin, Maroof Alam, Kwok-Kin Wong & Donald Kufe. (2014) MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells. Oncotarget 5:19, pages 8893-8905.
Crossref
RAN AO, DAO-RONG ZHANG, YA-QI DU & YING WANG. (2014) Expression and significance of Pin1, β-catenin and cyclin D1 in hepatocellular carcinoma. Molecular Medicine Reports 10:4, pages 1893-1898.
Crossref
I H Lee, M Sohn, H J Lim, S Yoon, H Oh, S Shin, J H Shin, S-H Oh, J Kim, D K Lee, D Y Noh, D S Bae, J K Seong & Y S Bae. (2014) Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway. Oncogene 33:38, pages 4675-4684.
Crossref
Cassandra J. Vandenberg, Paul Waring, Andreas Strasser & Suzanne Cory. (2014) Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained. Blood 124:7, pages 1099-1109.
Crossref
Yuan Yuan, Hui Cai, Xiao-Jun Yang, Wei Li, Jin He, Tian-Kang Guo & Yi-Rong Chen. (2014) Liposome-mediated Induction of Apoptosis of Human Hepatoma Cells by C-Myc Antisense Phosphorothioate Oligodeoxynucleotide and 5-Fluorouracil. Asian Pacific Journal of Cancer Prevention 15:14, pages 5529-5533.
Crossref
Ju Zhang, Xiaomin Lou, Longyu Jin, Rongjia Zhou, Siqi Liu, Ningzhi Xu & D. Joshua Liao. (2014) Necrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptions. Oncoscience 1:6, pages 407-422.
Crossref
Jue Er Amanda Lee, Linda May Parsons & Leonie M. Quinn. (2021) MYC function and regulation in flies: how Drosophila has enlightened MYC cancer biology. AIMS Genetics 01:01, pages 081-098.
Crossref
Miklos JaszberenyiFerenc G. Rick, Petra PopovicsNorman L. Block, Marta ZarandiRen-Zhi CaiIrving VidaurreLuca SzalontayArumugam R. JayakumarAndrew V. Schally. (2013) Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists. Proceedings of the National Academy of Sciences 111:2, pages 781-786.
Crossref
Ying Liu, Yanan Liu, Licong Yang, Chengwen Cao, Yanhui Zhou & Jie Liu. (2014) Stabilization for loop isomers of c-myc G-quadruplex DNA and anticancer activity by ruthenium complexes. Med. Chem. Commun. 5:11, pages 1724-1728.
Crossref
Baltazar D. Aguda. 2014. Molecular Diagnostics and Treatment of Pancreatic Cancer. Molecular Diagnostics and Treatment of Pancreatic Cancer 281 296 .
Pin Guo, Quanmin Nie, Jin Lan, Jianwei Ge, Yongming Qiu & Qing Mao. (2013) C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells. Biochemical and Biophysical Research Communications 441:1, pages 186-190.
Crossref
O V Leontieva, Z N Demidenko & M V Blagosklonny. (2013) MEK drives cyclin D1 hyperelevation during geroconversion. Cell Death & Differentiation 20:9, pages 1241-1249.
Crossref
Omran Abu Aboud, Hiromi I. Wettersten & Robert H. Weiss. (2013) Inhibition of PPARα Induces Cell Cycle Arrest and Apoptosis, and Synergizes with Glycolysis Inhibition in Kidney Cancer Cells. PLoS ONE 8:8, pages e71115.
Crossref
Sukhbir Kaur, David R. Soto-Pantoja, Erica V. Stein, Chengyu Liu, Abdel G. Elkahloun, Michael L. Pendrak, Alina Nicolae, Satya P. Singh, Zuqin Nie, David Levens, Jeffrey S. Isenberg & David D. Roberts. (2013) Thrombospondin-1 Signaling through CD47 Inhibits Self-renewal by Regulating c-Myc and Other Stem Cell Transcription Factors. Scientific Reports 3:1.
Crossref
Y Sun, S Cao, M Yang, S Wu, Z Wang, X Lin, X Song & D J Liao. (2012) Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4. Oncogene 32:14, pages 1794-1810.
Crossref
Guihua Wang, Feng Wang, Weifeng Ding, Jingchun Wang, Rongrong Jing, Haiquan Li, Xudong Wang, Yueguo Wang, Shaoqing Ju & Huimin Wang. (2013) APRIL Induces Tumorigenesis and Metastasis of Colorectal Cancer Cells via Activation of the PI3K/Akt Pathway. PLoS ONE 8:1, pages e55298.
Crossref
Mikhail V. Blagosklonny. (2012) Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions. Oncotarget 3:12, pages 1711-1724.
Crossref
Jue Lee, Nicola Cranna, Arjun Chahal & Leonie Quinn. (2012) Genetic Systems to Investigate Regulation of Oncogenes and Tumour Suppressor Genes in Drosophila. Cells 1:4, pages 1182-1196.
Crossref
James A. McCubrey, Linda S. Steelman, William H. Chappell, Stephen L. Abrams, Giuseppe Montalto, Melchiorre Cervello, Ferdinando Nicoletti, Paolo Fagone, Grazia Malaponte, Maria C. Mazzarino, Saverio Candido, Massimo Libra, Jörg Bäsecke, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Michele Milella, Agostino Tafuri, Lucio Cocco, Camilla Evangelisti, Francesca Chiarini & Alberto M. Martelli. (2012) Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response.. Oncotarget 3:9, pages 954-987.
Crossref
A. A. Stepanenko & V. M. Kavsan. (2012) Immortalization and malignant transformation of Eukaryotic cells. Cytology and Genetics 46:2, pages 96-129.
Crossref
Chih-Cheng Lin. (2012) Potential roles of longan flower and seed extracts for anti-cancer. World Journal of Experimental Medicine 2:4, pages 78.
Crossref
Bijal Shah, Peter Martin, Jianguo Tao & Eduardo M. Sotomayor. 2012. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics 113 135 .
Margaret Redpath, Bin Xu, Leon C. van Kempen & Alan Spatz. (2011) The dual role of the X-linked FoxP3 gene in human cancers. Molecular Oncology 5:2, pages 156-163.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.